Key Financial Data Of Group

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7344479

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
Key financial data of group
Business results of group
Net sales
173,455,000,000 JPY
139,303,000,000 JPY
166,258,000,000 JPY
132,167,000,000 JPY
129,585,000,000 JPY
155,252,000,000 JPY
150,514,000,000 JPY
129,733,000,000 JPY
158,340,000,000 JPY
135,763,000,000 JPY
Ordinary profit (loss)
27,330,000,000 JPY
24,246,000,000 JPY
28,281,000,000 JPY
24,535,000,000 JPY
23,512,000,000 JPY
28,015,000,000 JPY
27,726,000,000 JPY
25,314,000,000 JPY
27,851,000,000 JPY
23,242,000,000 JPY
Profit (loss) attributable to owners of parent
20,338,000,000 JPY
20,022,000,000 JPY
19,715,000,000 JPY
19,205,000,000 JPY
19,139,000,000 JPY
Comprehensive income
25,957,000,000 JPY
22,801,000,000 JPY
23,160,000,000 JPY
15,710,000,000 JPY
19,754,000,000 JPY
Net assets
204,816,000,000 JPY
169,626,000,000 JPY
197,900,000,000 JPY
167,895,000,000 JPY
170,785,000,000 JPY
195,600,000,000 JPY
163,454,000,000 JPY
182,583,000,000 JPY
172,657,000,000 JPY
154,433,000,000 JPY
Total assets
267,473,000,000 JPY
223,936,000,000 JPY
255,827,000,000 JPY
219,400,000,000 JPY
222,250,000,000 JPY
252,554,000,000 JPY
215,141,000,000 JPY
238,366,000,000 JPY
233,732,000,000 JPY
209,701,000,000 JPY
Net assets per share
2,749.17
2,275.79
2,600.04
2,205.31
2,196.31
2,515.53
2,091.20
2,335.93
2,208.94
1,975.79
Basic earnings (loss) per share
268.16
238.06
259.63
235.58
218.07
252.36
245.71
223.82
244.08
214.25
Diluted earnings per share
259.59
235.54
Equity-to-asset ratio
0.764 xbrli:pure
0.755 xbrli:pure
0.773 xbrli:pure
0.764 xbrli:pure
0.768 xbrli:pure
0.774 xbrli:pure
0.760 xbrli:pure
0.766 xbrli:pure
0.739 xbrli:pure
0.736 xbrli:pure
Rate of return on equity
0.101 xbrli:pure
0.107 xbrli:pure
0.102 xbrli:pure
0.107 xbrli:pure
0.102 xbrli:pure
0.104 xbrli:pure
0.108 xbrli:pure
0.110 xbrli:pure
0.113 xbrli:pure
0.110 xbrli:pure
Price-earnings ratio
25.3 xbrli:pure
28.5 xbrli:pure
34.8 xbrli:pure
38.3 xbrli:pure
41.5 xbrli:pure
35.8 xbrli:pure
51.3 xbrli:pure
56.3 xbrli:pure
38.0 xbrli:pure
43.3 xbrli:pure
Net cash provided by (used in) operating activities
18,360,000,000 JPY
31,914,000,000 JPY
22,419,000,000 JPY
23,986,000,000 JPY
20,089,000,000 JPY
Net cash provided by (used in) investing activities
-19,576,000,000 JPY
-14,312,000,000 JPY
7,991,000,000 JPY
-12,656,000,000 JPY
-5,072,000,000 JPY
Net cash provided by (used in) financing activities
-19,463,000,000 JPY
-20,759,000,000 JPY
-10,377,000,000 JPY
-6,019,000,000 JPY
-14,581,000,000 JPY
Cash and cash equivalents
59,690,000,000 JPY
79,480,000,000 JPY
81,987,000,000 JPY
61,157,000,000 JPY
56,272,000,000 JPY
Number of employees
279 xbrli:pure
3,534 xbrli:pure
1,366 xbrli:pure
38 xbrli:pure
2,173 xbrli:pure
973 xbrli:pure
1,645 xbrli:pure
1,328 xbrli:pure
xbrli:pure
109 xbrli:pure
3,146 xbrli:pure
279 xbrli:pure
3,495 xbrli:pure
1,631 xbrli:pure
1,607 xbrli:pure
3,451 xbrli:pure
1,589 xbrli:pure
3,473 xbrli:pure
3,435 xbrli:pure
1,414 xbrli:pure
Average number of temporary employees
17 xbrli:pure
472 xbrli:pure
100 xbrli:pure
xbrli:pure
344 xbrli:pure
1 xbrli:pure
117 xbrli:pure
100 xbrli:pure
xbrli:pure
110 xbrli:pure
345 xbrli:pure
17 xbrli:pure
518 xbrli:pure
151 xbrli:pure
151 xbrli:pure
528 xbrli:pure
154 xbrli:pure
542 xbrli:pure
557 xbrli:pure
160 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.